Header Logo

Connection

Cynthia Campbell to Substance-Related Disorders

Back to Details
This is a "connection" page, showing publications Cynthia Campbell has written about Substance-Related Disorders.
Cynthia Campbell
Connection Strength
5.958
Substance-Related Disorders
  1. Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system. J Subst Abuse Treat. 2020 11; 118:108097.
    View in: PubMed
    Score: 0.514
  2. Characteristics of patients with substance use disorder before and after the Affordable Care Act. Drug Alcohol Depend. 2018 12 01; 193:124-130.
    View in: PubMed
    Score: 0.453
  3. Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy. Subst Use Misuse. 2017 08 24; 52(10):1283-1291.
    View in: PubMed
    Score: 0.407
  4. Socioeconomic differences in adolescent substance abuse treatment participation and long-term outcomes. Addict Behav. 2017 05; 68:45-51.
    View in: PubMed
    Score: 0.401
  5. Marijuana use and service utilization among adolescents 7 years post substance use treatment. Drug Alcohol Depend. 2016 Nov 01; 168:1-7.
    View in: PubMed
    Score: 0.391
  6. High-Deductible Health Plans: Implications for Substance Use Treatment. Health Serv Res. 2016 10; 51(5):1939-59.
    View in: PubMed
    Score: 0.376
  7. 12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug Alcohol Depend. 2012 Nov 01; 126(1-2):124-30.
    View in: PubMed
    Score: 0.291
  8. Peer influences on adolescent alcohol and other drug use outcomes. J Nurs Scholarsh. 2012 Mar; 44(1):36-44.
    View in: PubMed
    Score: 0.286
  9. Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat. 2009 Jul; 37(1):64-72.
    View in: PubMed
    Score: 0.229
  10. Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization. Addict Behav. 2009 Feb; 34(2):171-9.
    View in: PubMed
    Score: 0.227
  11. Tailoring of outpatient substance abuse treatment to women, 1995-2005. Med Care. 2007 Aug; 45(8):775-80.
    View in: PubMed
    Score: 0.209
  12. Tailored treatment in the outpatient substance abuse treatment sector: 1995-2005. J Subst Abuse Treat. 2008 Apr; 34(3):282-92.
    View in: PubMed
    Score: 0.207
  13. Do licensing and accreditation matter in outpatient substance abuse treatment programs? J Subst Abuse Treat. 2007 Jul; 33(1):43-50.
    View in: PubMed
    Score: 0.201
  14. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J Adolesc Health. 2006 Apr; 38(4):343-50.
    View in: PubMed
    Score: 0.190
  15. Health services for women in outpatient substance abuse treatment. Health Serv Res. 2005 Jun; 40(3):781-810.
    View in: PubMed
    Score: 0.179
  16. Administrative burden and its implications for outpatient substance abuse treatment organizations. Psychiatr Serv. 2003 May; 54(5):705-11.
    View in: PubMed
    Score: 0.155
  17. Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Drug Alcohol Depend. 2023 Jan 01; 242:109711.
    View in: PubMed
    Score: 0.151
  18. Patterns of Health Care Use 5 Years After an Intervention Linking Patients in Addiction Treatment With a Primary Care Practitioner. JAMA Netw Open. 2022 11 01; 5(11):e2241338.
    View in: PubMed
    Score: 0.150
  19. Culturally competent treatment practices and ancillary service use in outpatient substance abuse treatment. J Subst Abuse Treat. 2002 Apr; 22(3):109-19.
    View in: PubMed
    Score: 0.144
  20. Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies. J Addict Med. 2020 12; 14(6):e293-e296.
    View in: PubMed
    Score: 0.131
  21. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2020 03; 112S:4-11.
    View in: PubMed
    Score: 0.125
  22. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose. Drug Alcohol Depend. 2020 04 01; 209:107923.
    View in: PubMed
    Score: 0.124
  23. 12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity. Subst Abus. 2013; 34(1):33-42.
    View in: PubMed
    Score: 0.076
  24. Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med. 2012 Jul-Aug; 10(4):304-11.
    View in: PubMed
    Score: 0.073
  25. Twelve-Step attendance trajectories over 7 years among adolescents entering substance use treatment in an integrated health plan. Addiction. 2012 May; 107(5):933-42.
    View in: PubMed
    Score: 0.071
  26. Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan. Int J Psychiatry Med. 2010; 40(1):57-76.
    View in: PubMed
    Score: 0.062
  27. Three-year chemical dependency and mental health treatment outcomes among adolescents: the role of continuing care. Alcohol Clin Exp Res. 2009 Aug; 33(8):1417-29.
    View in: PubMed
    Score: 0.059
  28. Twelve-Step affiliation and 3-year substance use outcomes among adolescents: social support and religious service attendance as potential mediators. Addiction. 2009 Jun; 104(6):927-39.
    View in: PubMed
    Score: 0.058
  29. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012 Mar; 13(3):266-75.
    View in: PubMed
    Score: 0.018

© 2025 Kaiser Permanente